Home / Health / Cervical Cancer Test Change: Self-Swabs Coming 2027
Cervical Cancer Test Change: Self-Swabs Coming 2027
5 Jan
Summary
- Self-swab HPV tests will be covered by insurers starting in 2027.
- New guidelines recommend HPV tests every five years for women 30-65.
- Screening rates declined post-pandemic, with a quarter untested.
Beginning January 1, 2027, private insurers in the U.S. will be required to cover self-administered HPV tests for cervical cancer screening. These new federal guidelines from the Health Resources and Services Administration (HRSA) update recommendations for women aged 30 to 65 with average risk, allowing them to opt for a self-swab HPV test every five years.
This shift away from the traditional Pap smear as the primary screening method for this age group is based on research showing increased detection of abnormal cells with HPV tests. While Pap smears will still be available and recommended every three years for women aged 21-29, HPV testing is now preferred for older demographics. Studies confirm self-swab tests are as accurate as those performed by clinicians.
This initiative seeks to address declining cervical cancer screening rates in the U.S., which saw a drop from 47% in 2019 to 41% in 2023. Federal health officials believe expanding choices, reducing barriers, and eliminating patient costs will empower women and improve health outcomes, especially for those in rural areas or with limited clinic access.
